Nickolas Mark

Nickolas Mark currently serves as the Managing Partner at Intermountain Ventures since January 2019 and holds multiple roles as an Investor and Advisor in several companies, including Octave, Culmination Bio, Vivante Health, Transcarent, Freenome, Saama, Vori Health, Leiters, and Axuall, Inc. In addition to extensive experience in venture capital and advisory capacities, Nickolas Mark co-founded Culmination Bio in March 2022. Educational qualifications include an MBA from Duke University's Fuqua School of Business, a BS in Economics from the University of Utah, training in the Genetics and Genomics Program at Stanford University, Executive Education from Harvard Business School, and studies at The Wharton School.